Advertisement

Premature Ovarian Failure

  • Victoria Sundblad
  • Violeta A.Chiauzzi
  • Eduardo H. Charreau
Part of the Contemporary Endocrinology book series (COE)

Keywords

Ovarian Failure Primordial Follicle Premature Ovarian Failure Secondary Amenorrhea Indirect Immunofluorescence Technique 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Pettersson F, Fries H, Nillius SJ. Epidemiology of secondary amenorrhea. I. Incidence and prevalence rates. Am J Obstet Gynecol 1973; 117:80–86.PubMedGoogle Scholar
  2. 2.
    Bachmann GA, Kemmann E. Prevalence of oligomenorrhea and amenorrhea in a college population. Am J Obstet Gynecol 1982; 144:98–102.PubMedGoogle Scholar
  3. 3.
    Current evaluation of amenorrhea. Fertil Steril 2004; 82:266–272.Google Scholar
  4. 4.
    Moraes-Ruehsen M, Jones GS. Premature ovarian failure. Fertil Steril 1967; 18:440–461.PubMedGoogle Scholar
  5. 5.
    Yen SS, Tsai CC, Vandenberg G, Rebar R. Gonadotropin dynamics in patients with gonadal dysgenesis: a model for the study of gonadotropin regulation. J Clin Endocrinol Metab 1972; 35:897–904.PubMedGoogle Scholar
  6. 6.
    Kalantaridou SN, Davis SR, Nelson LM. Premature ovarian failure. Endocrinol Metab Clin North Am 1998; 27:989–1006.PubMedGoogle Scholar
  7. 7.
    Rebar RW, Connolly HV. Clinical features of young women with hypergonadotropic amenorrhea. Fertil Steril 1990; 53:804–810.PubMedGoogle Scholar
  8. 8.
    Rebar RW, Cedars MI. Hypergonadotropic forms of amenorrhea in young women. Endocrinol Metab Clin North Am 1992; 21:173–191.PubMedGoogle Scholar
  9. 9.
    Nelson LM, Anasti JN, Kimzey LM, et al. Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. J Clin Endocrinol Metab 1994; 79:1470–1475.PubMedGoogle Scholar
  10. 10.
    Alper MM, Jolly EE, Garner PR. Pregnancies after premature ovarian failure. Obstet Gynecol 1986; 67:59S–62S.PubMedGoogle Scholar
  11. 11.
    Kreiner D, Droesch K, Navot D, Scott R, Rosenwaks Z. Spontaneous and pharmacologically induced remissions in patients with premature ovarian failure. Obstet Gynecol 1988; 72:926–928.PubMedGoogle Scholar
  12. 12.
    Ohsawa M, Wu MC, Masahashi T, Asai M, Narita O. Cyclic therapy resulted in pregnancy in premature ovarian failure. Obstet Gynecol 1985; 66:64S–67S.PubMedGoogle Scholar
  13. 13.
    Kinch RA, Plunkett ER, Smout MS, Carr DH. Primary ovarian failure; a clinicopathological and cytogenetic study. Am J Obstet Gynecol 1965; 91:630–644.PubMedGoogle Scholar
  14. 14.
    Hoek A, Schoemaker J, Drexhage HA. Premature ovarian failure and ovarian autoimmunity. Endocr Rev 1997; 18:107–134.PubMedGoogle Scholar
  15. 15.
    Jones GS, Moraes-Ruehsen M. A new syndrome of amenorrhae in association with hypergonadotropism and apparently normal ovarian follicular apparatus. Am J Obstet Gynecol 1969; 104:597–600.PubMedGoogle Scholar
  16. 16.
    Koninckx PR, Brosens IA. The “gonadotropin-resistant ovary” syndrome as a cause of secondary amenorrhea and infertility. Fertil Steril 1977; 28:926–931.PubMedGoogle Scholar
  17. 17.
    Christin-Maitre S, Vasseur C, Portnoi MF, Bouchard P. Genes and premature ovarian failure. Mol Cell Endocrinol 1998; 145:75–80.PubMedGoogle Scholar
  18. 18.
    Anasti JN. Premature ovarian failure: an update. Fertil Steril 1998; 70:1–15.PubMedGoogle Scholar
  19. 19.
    Waggoner DD, Buist NR, Donnell GN. Long-term prognosis in galactosaemia: results of a survey of 350 cases. J Inherit Metab Dis 1990; 13:802–818.PubMedGoogle Scholar
  20. 20.
    Coulam CB, Ryan RJ. Premature menopause. I. Etiology. Am J Obstet Gynecol 1979; 133:639–643.PubMedGoogle Scholar
  21. 21.
    LaBarbera AR, Miller MM, Ober C, Rebar RW. Autoimmune etiology in premature ovarian failure. Am J Reprod Immunol Microbiol 1988; 16:115–122.PubMedGoogle Scholar
  22. 22.
    Coulam CB. The prevalence of autoimmune disorders among patients with primary ovarian failure. Am J Reprod Immunol 1983; 4:63–66.PubMedGoogle Scholar
  23. 23.
    Kamp P, Platz P, Nerup J. “Steroid-cell” antibody in endocrine diseases.Acta Endocrinol (Copenh) 1974; 76:729–740.Google Scholar
  24. 24.
    Board JA, Redwine FO, Moncure CW, Frable WJ, Taylor JR. Identification of differing etiologies of clinically diagnosed premature menopause. Am J Obstet Gynecol 1979; 134:936–944.PubMedGoogle Scholar
  25. 25.
    Elder M, Maclaren N, Riley W. Gonadal autoantibodies in patients with hypogonadism and/or Addison’s disease. J Clin Endocrinol Metab 1981; 52:1137–1142.PubMedGoogle Scholar
  26. 26.
    Coulam CB, Kempers RD, Randall RV. Premature ovarian failure: evidence for the autoimmune mechanism. Fertil Steril 1981; 36:238–240.PubMedGoogle Scholar
  27. 27.
    Fenichel P, Sosset C, Barbarino-Monnier P et al. Prevalence, specificity and significance of ovarian antibodies during spontaneous premature ovarian failure. Hum Reprod 1997; 12:2623–2628.PubMedGoogle Scholar
  28. 28.
    Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986; 67:604–606.PubMedGoogle Scholar
  29. 29.
    Krailo MD, Pike MC. Estimation of the distribution of age at natural menopause from prevalence data. Am J Epidemiol 1983; 117:356–361.PubMedGoogle Scholar
  30. 30.
    Cramer DW, Xu H. Predicting age at menopause. Maturitas 1996; 23:319–326.PubMedGoogle Scholar
  31. 31.
    Luborsky JL, Meyer P, Sowers MF, Gold EB, Santoro N. Premature menopause in a multi-ethnic population study of the menopause transition. Hum Reprod 2003; 18:199–206.PubMedGoogle Scholar
  32. 32.
    Forges T, Monnier-Barbarino P, Faure GC, Bene MC. Autoimmunity and antigenic targets in ovarian pathology. Hum Reprod Update 2004; 10:163–175.PubMedGoogle Scholar
  33. 33.
    Wheatcroft NJ, Toogood AA, Li TC, Cooke ID, Weetman AP. Detection of antibodies to ovarian antigens in women with premature ovarian failure. Clin Exp Immunol 1994; 96:122–128.PubMedGoogle Scholar
  34. 34.
    Luborsky J. Ovarian autoimmune disease and ovarian autoantibodies. J Womens Health Gend Based Med 2002; 11:585–599.PubMedGoogle Scholar
  35. 35.
    Aiman J, Smentek C. Premature ovarian failure. Obstet Gynecol 1985; 66:9–14.PubMedGoogle Scholar
  36. 36.
    Conway GS, Kaltsas G, Patel A, Davies MC, Jacobs HS. Characterization of idiopathic premature ovarian failure. Fertil Steril 1996; 65:337–341.PubMedGoogle Scholar
  37. 37.
    Alper MM, Garner PR. Premature ovarian failure: its relationship to autoimmune disease. Obstet Gynecol 1985; 66:27–30.PubMedGoogle Scholar
  38. 38.
    Betterle C, Rossi A, Dalla PS, et al. Premature ovarian failure: autoimmunity and natural history. Clin Endocrinol (Oxf) 1993; 39:35–43.Google Scholar
  39. 39.
    de Moraes RM, Blizzard RM, Garcia-Bunuel R, Jones GS. Autoimmunity and ovarian failure. Am J Obstet Gynecol 1972; 112:693–703.Google Scholar
  40. 40.
    Rebar RW, Erickson GF, Yen SS. Idiopathic premature ovarian failure: clinical and endocrine characteristics. Fertil Steril 1982; 37:35–41.PubMedGoogle Scholar
  41. 41.
    Uibo R, Perheentupa J, Ovod V, Krohn KJ. Characterization of adrenal autoantigens recognized by sera from patients with autoimmune polyglandular syndrome (APS) type I. J Autoimmun 1994; 7:399–411.PubMedGoogle Scholar
  42. 42.
    Irvine WJ, Chan MM, Scarth L, et al. Immunological aspects of premature ovarian failure associated with idiopathic Addison’s disease. Lancet 1968; 2:883–887.PubMedGoogle Scholar
  43. 43.
    Sotsiou F, Bottazzo GF, Doniach D. Immunofluorescence studies on autoantibodies to steroid-producing cells, and to germline cells in endocrine disease and infertility. Clin Exp Immunol 1980; 39:97–111.PubMedGoogle Scholar
  44. 44.
    Betterle C, Volpato M. Adrenal and ovarian autoimmunity. Eur J Endocrinol 1998; 138:16–25.PubMedGoogle Scholar
  45. 45.
    Ahonen P, Miettinen A, Perheentupa J. Adrenal and steroidal cell antibodies in patients with autoimmune polyglandular disease type I and risk of adrenocortical and ovarian failure. J Clin Endocrinol Metab 1987; 64:494–500.PubMedGoogle Scholar
  46. 46.
    Irvine WJ, Chan MM, Scarth L. The further characterization of autoantibodies reactive with extra-adrenal steroid-producing cells in patients with adrenal disorders. Clin Exp Immunol 1969; 4:489–503.PubMedGoogle Scholar
  47. 47.
    McNatty KP, Short RV, Barnes EW, Irvine WJ. The cytotoxic effect of serum from patients with Addison’s disease and autoimmune ovarian failure on human granulosa cells in culture. Clin Exp Immunol 1975; 22:378–384.PubMedGoogle Scholar
  48. 48.
    Krohn K, Uibo R, Aavik E, Peterson P, Savilahti K. Identification by molecular cloning of an autoantigen associated with Addison’s disease as steroid 17 alpha-hydroxylase. Lancet 1992; 339:770–773.PubMedGoogle Scholar
  49. 49.
    Winqvist O, Gustafsson J, Rorsman F, Karlsson FA, Kampe O. Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison’s disease. J Clin Invest 1993; 92:2377–2385.PubMedGoogle Scholar
  50. 50.
    Uibo R, Aavik E, Peterson P, et al. Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison’s disease. J Clin Endocrinol Metab 1994;78:323–328.PubMedGoogle Scholar
  51. 51.
    Arif S, Vallian S, Farzaneh F, et al. Identification of 3 beta-hydroxysteroid dehydrogenase as a novel target of steroid cell autoantibodies: association of autoantibodies with endocrine autoimmune disease. J Clin Endocrinol Metab 1996; 81:4439–4445.PubMedGoogle Scholar
  52. 52.
    Chen S, Sawicka J, Betterle C, et al. Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison’s disease, and premature ovarian failure. J Clin Endocrinol Metab 1996; 81:1871–1876.PubMedGoogle Scholar
  53. 53.
    Peterson P, Uibo R, Peranen J, Krohn K. Immunoprecipitation of steroidogenic enzyme autoantigens with autoimmune polyglandular syndrome type I (APS I) sera; further evidence for independent humoral immunity to P450c17 and P450c21. Clin Exp Immunol 1997; 107:335–340.PubMedGoogle Scholar
  54. 54.
    Falorni A, Laureti S, Candeloro P, et al. Steroid-cell autoantibodies are preferentially expressed in women with premature ovarian failure who have adrenal autoimmunity. Fertil Steril 2002; 78:270–279.PubMedGoogle Scholar
  55. 55.
    Dal Pra C, Chen S, Furmaniak J, et al. Autoantibodies to steroidogenic enzymes in patients with premature ovarian failure with and without Addison’s disease. Eur J Endocrinol 2003; 148:565–570.PubMedGoogle Scholar
  56. 56.
    Reimand K, Peterson P, Hyoty H, et al. 3beta-hydroxysteroid dehydrogenase autoantibodies are rare in premature ovarian failure. J Clin Endocrinol Metab 2000; 85:2324–2326.PubMedGoogle Scholar
  57. 57.
    Fox H. The pathology of premature ovarian failure. J Pathol 1992; 167:357–363.PubMedGoogle Scholar
  58. 58.
    Bakalov VK, Anasti JN, Calis KA, et al. Autoimmune oophoritis as a mechanism of follicular dysfunction in women with 46,XX spontaneous premature ovarian failure. Fertil Steril 2005; 84:958–965.PubMedGoogle Scholar
  59. 59.
    Gloor E, Hurlimann J. Autoimmune oophoritis. Am J Clin Pathol 1984; 81:105–109.PubMedGoogle Scholar
  60. 60.
    Bussmann L, Chiauzzi V, Cortelezzi M, Comparato M, Charreau EH. Autoinmunidad y Falla Ovàrica. Medicina (Buenos Aires) 1991; 51:471.Google Scholar
  61. 61.
    Bussmann L, Chiauzzi VA, Charreau EH. Anticuerpos antiovario y falla ovàrica prematura. Medicina (Buenos Aires) 1998; 58:608.Google Scholar
  62. 62.
    Sundblad V, Chiauzzi V, Bussmann L, Charreau E. Identificaciòn de un autoantìgeno ovàrico en pacientes con falla ovàrica prematura (POF). Medicina (Buenos Aires) 2003; 63:633.Google Scholar
  63. 63.
    Damewood MD, Zacur HA, Hoffman GJ, Rock JA. Circulating antiovarian antibodies in premature ovarian failure. Obstet Gynecol 1986; 68:850–854.PubMedGoogle Scholar
  64. 64.
    Vallotton MB, Forbes AP. Antibodies to cytoplasm of ova. Lancet 1966; 2:264–265.PubMedGoogle Scholar
  65. 65.
    Drury MI, Keelan DM, Timoney FJ, Irvine WJ. Juvenile familial endocrinopathy. Clin Exp Immunol 1970; 7:125–132.PubMedGoogle Scholar
  66. 66.
    Williamson HO, Phansey SA, Mathur S, et al. Myasthenia gravis, premature menopause, and thyroid autoimmunity. Am J Obstet Gynecol 1980; 137:893–901.PubMedGoogle Scholar
  67. 67.
    Kamada M, Daitoh T, Mori K, et al. Etiological implication of autoantibodies to zona pellucida in human female infertility. Am J Reprod Immunol 1992; 28:104–109.PubMedGoogle Scholar
  68. 68.
    Gobert B, Jolivet-Reynaud C, Dalbon P, et al. An immunoreactive peptide of the FSH involved in autoimmune infertility. Biochem Biophys Res Commun 2001; 289:819–824.PubMedGoogle Scholar
  69. 69.
    Meyer WR, Lavy G, DeCherney AH, et al. Evidence of gonadal and gonadotropin antibodies in women with a suboptimal ovarian response to exogenous gonadotropin. Obstet Gynecol 1990; 75:795–799.PubMedGoogle Scholar
  70. 70.
    Luborsky JL, Visintin I, Boyers S, et al. Ovarian antibodies detected by immobilized antigen immunoassay in patients with premature ovarian failure. J Clin Endocrinol Metab 1990; 70:69–75.PubMedGoogle Scholar
  71. 71.
    Van Weissenbruch MM, Hoek A, Vliet-Bleeker I, Schoemaker J, Drexhage H. Evidence for existence of immunoglobulins that block ovarian granulosa cell growth in vitro. A putative role in resistant ovary syndrome? J Clin Endocrinol Metab 1991; 73:360–367.PubMedGoogle Scholar
  72. 72.
    Tang VW, Faiman C. Premature ovarian failure: a search for circulating factors against gonadotropin receptors. Am J Obstet Gynecol 1983; 146:816–821.PubMedGoogle Scholar
  73. 73.
    Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 46-1986. A 26-year-old woman with secondary amenorrhea. N Engl J Med 1986; 315:1336–1343.Google Scholar
  74. 74.
    Chiauzzi V, Cigorraga S, Escobar ME, Rivarola MA, Charreau EH. Inhibition of follicle-stimulating hormone receptor binding by circulating immunoglobulins. J Clin Endocrinol Metab 1982; 54:1221–1228.PubMedGoogle Scholar
  75. 75.
    Chiauzzi VA, Bussmann L, Calvo JC, Sundblad V, Charreau EH. Circulating immunoglobulins that inhibit the binding of follicle-stimulating hormone to its receptor: a putative diagnostic role in resistant ovary syndrome? Clin Endocrinol (Oxf) 2004; 61:46–54.Google Scholar
  76. 76.
    Austin GE, Coulam CB, Ryan RJ. A search for antibodies to luteinizing hormone receptors in premature ovarian failure. Mayo Clin Proc 1979; 54:394–400.PubMedGoogle Scholar
  77. 77.
    Escobar ME, Cigorraga SB, Chiauzzi VA, Charreau EH, Rivarola MA. Development of the gonadotrophic resistant ovary syndrome in myasthenia gravis: suggestion of similar autoimmune mechanisms. Acta Endocrinol (Copenh) 1982; 99:431–436.Google Scholar
  78. 78.
    Charreau EH, Cigorraga S, Chiauzzi V, Escobar ME,Rivarola MA. Receptors and antireceptors of the ovary. In: Tozzini RI, Reeves G, Pineda RL, editors. Endocrine Physiopathology of the Ovary. Elsevier/North Holland, Biomedical Press, 1980: 191–205.Google Scholar
  79. 79.
    Charreau EH, Chiauzzi V, Cigorraga S, Escobar ME, Rivarola M. Immunoglobulin anti FSH receptor in the resistant ovary syndrome. In: Thomas G. Muldoon, Virendra B. Mahesh and Bautista Palrez- Baltester, editors. Recent Advances in Fertility Research, Part A. Alan R. Liss, Inc. 150 Fifth Avenue,Google Scholar
  80. 80.
    Dias JA, Gates SA, Reichert LE Jr. Evidence for the presence of follicle-stimulating hormone receptor antibody in human serum. Fertil Steril 1982; 38:330–338.PubMedGoogle Scholar
  81. 81.
    Bannatyne P, Russell P, Shearman RP. Autoimmune oophoritis: a clinicopathologic assessment of 12 cases. Int J Gynecol Pathol 1990; 9:191–207.PubMedGoogle Scholar
  82. 82.
    Massin N, Gougeon A, Meduri G, et al. Significance of ovarian histology in the management of patients presenting a premature ovarian failure. Hum Reprod 2004; 19:2555–2560.PubMedGoogle Scholar
  83. 83.
    Pache TD, Wladimiroff JW, de Jong FH, Hop WC, Fauser BC. Growth patterns of nondominant ovarian follicles during the normal menstrual cycle. Fertil Steril 1990; 54:638–642.PubMedGoogle Scholar
  84. 84.
    Mehta AE, Matwijiw I, Lyons EA, Faiman C. Noninvasive diagnosis of resistant ovary syndrome by ultrasonography. Fertil Steril 1992; 57:56–61.PubMedGoogle Scholar
  85. 85.
    Winqvist O, Gebre-Medhin G, Gustafsson J, et al. Identification of the main gonadal autoantigens in patients with adrenal insufficiency and associated ovarian failure. J Clin Endocrinol Metab 1995; 80:1717–1723.PubMedGoogle Scholar
  86. 86.
    Betterle C, Volpato M, Pedini B, et al. Adrenal-cortex autoantibodies and steroid-producing cells autoantibodies in patients with Addison’s disease: comparison of immunofluorescence and immunoprecipitation assays. J Clin Endocrinol Metab 1999; 84:618–622.PubMedGoogle Scholar
  87. 87.
    Coulam CB, Ryan RJ. Prevalence of circulating antibodies directed toward ovaries among women with premature ovarian failure. Am J Reprod Immunol Microbiol 1985; 9:23–24.PubMedGoogle Scholar
  88. 88.
    Ho PC, Tang GW, Fu KH, Fan MC, Lawton JW. Immunologic studies in patients with premature ovarian failure. Obstet Gynecol 1988; 71:622–626.PubMedGoogle Scholar
  89. 89.
    Kirsop R, Brock CR, Robinson BG, et al. Detection of anti-ovarian antibodies by indirect immunofluorescence in patients with premature ovarian failure. Reprod Fertil Dev 1991; 3:537–541.PubMedGoogle Scholar
  90. 90.
    Wheatcroft NJ, Salt C, Milford-Ward A, Cooke ID, Weetman AP. Identification of ovarian antibodies by immunofluorescence, enzyme-linked immunosorbent assay or immunoblotting in premature ovarian failure. Hum Reprod 1997; 12:2617–2622.PubMedGoogle Scholar
  91. 91.
    Luborsky J, Llanes B, Davies S, et al. Ovarian autoimmunity: greater frequency of autoantibodies in premature menopause and unexplained infertility than in the general population. Clin Immunol 1999; 90:368–374.PubMedGoogle Scholar
  92. 92.
    Gobert B, Barabarino-Monnier P, Guillet-Rosso F, Bene MC, Faure GC. Ovary antibodies after IVF. Lancet 1990; 335:723.Google Scholar
  93. 93.
    Dewhurst CJ, de Koos EB, Ferreira HP. The resistant ovary syndrome. Br J Obstet Gynaecol 1975; 82:341–345.PubMedGoogle Scholar
  94. 94.
    Starup J, Sele V, Henriksen B. Amenorrhoea associated with increased production of gonadotrophins and a morphologically normal ovarian follicular apparatus. Acta Endocrinol (Copenh) 1971; 66:248–256.Google Scholar
  95. 95.
    Van Campenhout J, Vauclair R, Maraghi K. Gonadotropin–resistant ovaries in primary amenorrhea. Obstet Gynecol 1972; 40:6–12.PubMedGoogle Scholar
  96. 96.
    Anasti JN, Kalantaridou SN, Kimzey LM, Defensor RA, Nelson LM. Bone loss in young women with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol 1998; 91:12–15.PubMedGoogle Scholar
  97. 97.
    Davis SR, Burger HG. The rationale for physiological testosterone replacement in women. Baillieres Clin Endocrinol Metab 1998; 12:391–405.PubMedGoogle Scholar
  98. 98.
    Davis SR, McCloud P, Strauss BJ, Burger H. Testosterone enhances estradiol’s effects on postmenopausal bone density and sexuality. Maturitas 1995; 21:227–236.PubMedGoogle Scholar
  99. 99.
    Wright CS, Jacobs HS. Spontaneous pregnancy in a patient with hypergonadotrophic ovarian failure. Br J Obstet Gynaecol 1979; 86:389–392.PubMedGoogle Scholar
  100. 100.
    Rabinowe SL, Berger MJ, Welch WR, Dluhy RG. Lymphocyte dysfunction in autoimmune oophoritis. Resumption of menses with corticosteroids. Am J Med 1986; 81:347–350.PubMedGoogle Scholar
  101. 101.
    Cowchock FS, McCabe JL, Montgomery BB. Pregnancy after corticosteroid administration in premature ovarian failure (polyglandular endocrinopathy syndrome). Am J Obstet Gynecol 1988; 158:118–119.PubMedGoogle Scholar
  102. 102.
    Kalantaridou SN, Braddock DT, Patronas NJ, Nelson LM. Treatment of autoimmune premature ovarian failure. Hum Reprod 1999; 14:1777–1782.PubMedGoogle Scholar
  103. 103.
    Barbarino-Monnier P, Gobert B, Guillet-May F, et al. Ovarian autoimmunity and corticotherapy in an in-vitro fertilization attempt. Hum Reprod 1995; 10:2006–2007.PubMedGoogle Scholar
  104. 104.
    van Kasteren YM, Braat DD, Hemrika DJ, et al. Corticosteroids do not influence ovarian responsiveness to gonadotropins in patients with premature ovarian failure: a randomized, placebo-controlled trial. Fertil Steril 1999; 71:90–95.PubMedGoogle Scholar
  105. 105.
    Corenblum B, Rowe T, Taylor PJ. High-dose,short-term glucocorticoids for the treatment of infertility resulting from premature ovarian failure. Fertil Steril 1993; 59:988–991.PubMedGoogle Scholar
  106. 106.
    Blumenfeld Z, Halachmi S, Peretz BA, et al. Premature ovarian failure–the prognostic application of autoimmunity on conception after ovulation induction. Fertil Steril 1993; 59:750–755.PubMedGoogle Scholar
  107. 107.
    Bateman BG, Nunley WC Jr, Kitchin JD III. Reversal of apparent premature ovarian failure in a patient with myasthenia gravis. Fertil Steril 1983; 39:108–110.PubMedGoogle Scholar
  108. 108.
    Lundberg PO, Persson BH. Disappearance of amenorrhea after thymectomy. A case report. Acta Soc Med Ups 1969; 74:206–208.PubMedGoogle Scholar
  109. 109.
    Sauer MV, Paulson RJ, Ary BA, Lobo RA. Three hundred cycles of oocyte donation at the University of Southern California: assessing the effect of age and infertility diagnosis on pregnancy and implantation rates. J Assist Reprod Genet 1994; 11:92–96.PubMedGoogle Scholar
  110. 110.
    Sung L, Bustillo M, Mukherjee T, et al. Sisters of women with premature ovarian failure may not be ideal ovum donors. Fertil Steril 1997; 67:912–916.PubMedGoogle Scholar

Copyright information

© Humana Press Inc. 2007

Authors and Affiliations

  • Victoria Sundblad
  • Violeta A.Chiauzzi
  • Eduardo H. Charreau

There are no affiliations available

Personalised recommendations